Can You Take Escitalopram with Clonazepam?

Severity assessment

Moderate. The combination can increase central nervous system (CNS) depression, leading to enhanced sedation, dizziness, and impaired coordination.

Mechanism (plain English)

Clonazepam is a benzodiazepine that works by increasing the activity of a natural calming chemical in the brain called gamma-aminobutyric acid (GABA). This slows down brain activity, producing a calming effect. Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that increases the amount of serotonin, another natural brain chemical, available in the brain. While escitalopram primarily affects serotonin, it can also contribute to overall CNS depression. When taken together, the combined depressant effects on the brain can be additive, leading to more pronounced side effects like drowsiness and reduced alertness.

Evidence level

Guideline-supported. The British National Formulary (BNF) and other drug interaction checkers highlight the increased CNS depressant effects when these medications are co-administered [1, 2].

Top regulator advisories (cite verbatim or close paraphrase)

• TGA (Australia): No specific pair-specific public advisory found. However, the product information for clonazepam (e.g., Rivotril) generally advises caution with other CNS depressants due to additive effects. Similarly, escitalopram product information (e.g., Lexapro) warns about potential for CNS effects and interactions with other centrally acting drugs.
• MHRA / NICE (UK): The British National Formulary (BNF) states: "Both Clonazepam and Escitalopram have effects on the CNS and can cause sedation, which might affect the ability to perform skilled tasks" [1].
• FDA / CDC (US): The FDA label for escitalopram (Lexapro) warns about concomitant use with other serotonergic agents due to the risk of serotonin syndrome, though clonazepam is not typically considered serotonergic. More broadly, both clonazepam and escitalopram labels advise caution when co-administered with other CNS depressants due to additive effects on sedation and psychomotor impairment [3].
• EMA (Europe): No specific pair-specific public advisory found. Product information for both clonazepam and escitalopram generally advises caution with other CNS depressants.

Clinical risk factors that elevate the danger

• Elderly patients: Increased sensitivity to CNS depressant effects and slower drug metabolism.
• Patients with respiratory conditions: Increased risk of respiratory depression.
• Patients with liver impairment: Reduced metabolism of both drugs, leading to higher drug levels and increased side effects.
• Concomitant use of other CNS depressants: Alcohol, opioids, antihistamines, or other sedatives can significantly enhance sedative effects.
• High doses of either medication: Dose-dependent increase in CNS depression.
• Rapid dose escalation: Insufficient time for the body to adapt to the sedative effects.

What a patient should be told

• Risk of increased drowsiness and dizziness: You may feel more sleepy, dizzy, or have trouble concentrating. Be careful when driving or operating machinery until you know how these medications affect you.
• Do not stop suddenly: Do not stop taking either medication without talking to your doctor or pharmacist first. Suddenly stopping clonazepam can cause withdrawal symptoms, and stopping escitalopram abruptly can lead to discontinuation syndrome.
• Warning signs to watch for: Seek immediate medical attention if you experience extreme drowsiness, confusion, difficulty breathing, unusual muscle stiffness or twitching, or a fast heartbeat.
• Discuss alternatives: If you are concerned about these side effects, talk to your doctor or pharmacist about potential adjustments to your treatment plan or alternative medications.
• Urgent care triggers: Go to the nearest emergency room or call emergency services if you or someone you know experiences severe difficulty breathing, unresponsiveness, or seizures.

Top 3 sources (with full citation)

1. Clonazepam | Interactions | BNF - NICE. British National Formulary (BNF). National Institute for Health and Care Excellence (NICE). URL: https://bnf.nice.org.uk/interactions/clonazepam/
2. Escitalopram | Interactions | BNF - NICE. British National Formulary (BNF). National Institute for Health and Care Excellence (NICE). URL: https://bnf.nice.org.uk/interactions/escitalopram/
3. Lexapro (escitalopram) tablets, for oral use; Lexapro (escitalopram) oral solution. U.S. Food and Drug Administration (FDA). Revised 5/2023. Reference ID: 5173507. URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s055,021365s039lbl.pdf

Notes for the reviewing pharmacist

The co-prescription of benzodiazepines and SSRIs is common in clinical practice, particularly for anxiety disorders with comorbid depression. While the primary concern is additive CNS depression, the combination is often used to manage initial SSRI-induced anxiety or for short-term anxiolysis. It is crucial to educate patients on the potential for increased sedation and to monitor for signs of respiratory depression, especially in vulnerable populations. Gradual tapering of clonazepam is essential to prevent withdrawal seizures. Although escitalopram is serotonergic, clonazepam does not directly impact serotonin levels, so serotonin syndrome risk from this specific combination is low unless other serotonergic agents are involved. However, vigilance for any unusual neurological symptoms is always warranted. The FDA label for escitalopram mentions general caution with CNS depressants, reinforcing the need for careful patient counseling and monitoring. The BNF explicitly highlights the CNS depressant effects of both drugs when used together.

Source metadata JSON

{
  "pair": "clonazepam + escitalopram",
  "severity": "Moderate",
  "evidence_level": "Guideline-supported",
  "source_urls": "https://bnf.nice.org.uk/interactions/clonazepam/;https://bnf.nice.org.uk/interactions/escitalopram/;https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s055,021365s039lbl.pdf"
}